Literature DB >> 23105608

Immune response to n-terminal and c-terminal deletion mutants of Aspergillus fumigatus major allergen ASP F 3.

Bhanu P Singh1, Banani Banerjee, Puspanita Naik, Jordan N Fink, Viswanath P Kurup.   

Abstract

The ubiquitous fungus Aspergillus fumigatus causes allergic rhinitis, asthma, sinusitis and allergic bronchopulmonary aspergillosis. A number of major allergens from A. fumigatus are purified, but their structure-function role in the pathogenesis of disease is not known. Such information is essential for devising alternative therapy of fungal allergic diseases. In the present study, N-terminal and C-terminal deletion mutants ofAsp f 3 were constructed and their immunopathological responses studied in a mice model of allergy. Three mutants viz,Asp f 3 (aa 33-168), (aa 1-142), and (aa 23-142) were made by deleting certain amino acids from epitopic regions of full lengthAsp f 3, a major allergen of A. furnigatus. TheAsp f 3 and three mutated proteins were expressed in pET vector. The C-terminal deletion mutantAsp f 3 (aa 1-142) induced elevated IFN-γ but low levels of IL-4 by spleen cells. This mutant also showed significant downregulation of peripheral blood eosinophils and lung inflammation in immunized mice. The N-terminal deletion mutantAsp f 3 (aa 33-168) also exhibited an immuno-suppressive effect in terms of IgE production and induction of Th2 cytokine. The results indicate thatrAsp f 3 and its deletion mutants induced distinct immune-inflammatory responses in mice on challenge with these proteins. The non-IgE binding deletion mutants ofAsp f 3 (aa 1-142 and aa 33-168) could deviate Th2 immune response with a concomitant reduction in airway inflammation and infiltration of inflammatory cells.

Entities:  

Keywords:  ABPA; Aspergillus fumigatus; Deletion mutants; Murine model; rAsp f 3

Year:  2006        PMID: 23105608      PMCID: PMC3453993          DOI: 10.1007/BF02912906

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  24 in total

1.  Skin test reactivity to 2 recombinant Aspergillus fumigatus allergens in A fumigatus-sensitized asthmatic subjects allows diagnostic separation of allergic bronchopulmonary aspergillosis from fungal sensitization.

Authors:  S Hemmann; G Menz; C Ismail; K Blaser; R Crameri
Journal:  J Allergy Clin Immunol       Date:  1999-09       Impact factor: 10.793

2.  IgG1, IgG4 and IgE antibody reactivity to mutant forms of the major dust mite allergen Lep d 2 among atopic and nonatopic subjects naturally exposed to Lepidoglyphus destructor.

Authors:  S Olsson; M van Hage-Hamsten; C G Magnusson
Journal:  Int Arch Allergy Immunol       Date:  2001-09       Impact factor: 2.749

3.  Purified recombinant A. fumigatus allergens induce different responses in mice.

Authors:  V P Kurup; J Q Xia; R Crameri; D A Rickaby; H Y Choi; S Flückiger; K Blaser; C A Dawson; K J Kelly
Journal:  Clin Immunol       Date:  2001-03       Impact factor: 3.969

4.  Antibody binding of deletion mutants of Asp f 2, the major Aspergillus fumigatus allergen.

Authors:  B Tang; B Banerjee; P A Greenberger; J N Fink; K J Kelly; V P Kurup
Journal:  Biochem Biophys Res Commun       Date:  2000-04-21       Impact factor: 3.575

Review 5.  Genetically engineered and synthetic allergen derivatives: candidates for vaccination against type I allergy.

Authors:  R Valenta; S Vrtala; M Focke-Tejkl; T Ball; A Twardosz; S Spitzauer; H Grönlund; D Kraft
Journal:  Biol Chem       Date:  1999 Jul-Aug       Impact factor: 3.915

6.  Long-term clinical efficacy of grass-pollen immunotherapy.

Authors:  S R Durham; S M Walker; E M Varga; M R Jacobson; F O'Brien; W Noble; S J Till; Q A Hamid; K T Nouri-Aria
Journal:  N Engl J Med       Date:  1999-08-12       Impact factor: 91.245

7.  Allergen-specific T-cell tolerance induction with allergen-derived long synthetic peptides: results of a phase I trial.

Authors:  Jean-Marc Fellrath; Alexander Kettner; Nathalie Dufour; Christian Frigerio; Dominique Schneeberger; Annette Leimgruber; Gampietro Corradin; François Spertini
Journal:  J Allergy Clin Immunol       Date:  2003-04       Impact factor: 10.793

8.  Selected recombinant Aspergillus fumigatus allergens bind specifically to IgE in ABPA.

Authors:  V P Kurup; B Banerjee; S Hemmann; P A Greenberger; K Blaser; R Crameri
Journal:  Clin Exp Allergy       Date:  2000-07       Impact factor: 5.018

9.  Integrated signals between IL-13, IL-4, and IL-5 regulate airways hyperreactivity.

Authors:  D C Webb; A N McKenzie; A M Koskinen; M Yang; J Mattes; P S Foster
Journal:  J Immunol       Date:  2000-07-01       Impact factor: 5.422

10.  Disease-specific recombinant allergens for the diagnosis of allergic bronchopulmonary aspergillosis.

Authors:  R Crameri; S Hemmann; C Ismail; G Menz; K Blaser
Journal:  Int Immunol       Date:  1998-08       Impact factor: 4.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.